California continues to lead the nation in HMO enrollment, with 55% of the state's population participating in an HMO plan, according to a survey released by Medical Data International, Santa Ana, CA.
California continues to lead the nation in HMO enrollment, with 55% of the state's population participating in an HMO plan, according to a survey released by Medical Data International, Santa Ana, CA.
Two-thirds of the 50 states - a total of 33 - increased in HMO enrollment since last year's survey. Highest increases were east of the Mississippi, with Pennsylvania's HMO penetration climbing 15% over the previous year.
Although the West Coast, especially California, continued to show strong numbers, enrollments in Oregon and Utah actually dropped slightly (3% and 2%, respectively). Another dozen states remained essentially flat.
According to the survey, states reporting lowest enrollments tended to be in the northern part of the country. These included Alaska, with virtually no HMO enrollees, and Wyoming and North Dakota, with 3% each. Lowest enrolling Metropolitan Statistical Areas were in the Midwest and the South: Greenville, SC, tallied 14%; Birmingham, AL, 18%; and New Orleans, and Wichita, KS, each totaled 24%.
MDI also looked at 65 large metropolitan statistical areas. In most (80%) of these major population centers, at least one-third of residents are now enrolled in HMO plans, when only about half of the MSAs showed enrollments of one-third or more. According to the survey, the highest enrolling MSA in the country is now Sacramento, CA, at 82% penetration, followed by San Francisco, with 72%. Rochester, NY, the previous year's leader, fell to third place, at 68%.
HMO penetration data for all states and the 65 MSAs is reported in visual format on the 2000 version of MDI's annual "Managed Care Profile Map," a four-color, poster-size graphic. More information is available on MDI's Web site: www.medicaldata.com. PR
Young & Partners Pharmaceutical Executive Summit 2024: Brave New World – Where Are We Heading?
October 23rd 2024Peter Marks, director, Center for Biologics Evaluation and Research, FDA, presented the keynote presentation on the future of gene therapy as part of the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.